Report an error

Spotted something inaccurate in “Sequential Rivaroxaban-to-Aspirin Protocol Cuts Clot Risk Post-Joint-Replacement”? Tell us what’s wrong and we’ll check it against the original source.

Website

Send report Cancel

This form is for factual corrections. We read every report but cannot reply individually.